跳至主要内容
临床试验/NCT00746915
NCT00746915Unknown1 期

A Prospective, Single-Center, Phase I Study Evaluating the Safety and Initial Efficacy of the Epidetect Device for Collection of Bioimpedance Data of Human Tissues in Patients Undergoing Elective Pain Relief Treatment of Lumbar Epidural Steroid Injection Under Fluoroscopy

ImpediGuide Ltd1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年3月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
20
试验地点
1
主要终点
Safety variables collected will include the incidence of adverse events presented by severity, by seriousness and by relationship to study treatment

研究概览

简要总结

The objectives of this study are to evaluate the safety and initial efficacy of the epidural injection procedure when combined with real-time multi-frequency bio-impedance measurements that collect data on the electrical bioimpedance characteristics of living human tissue on the path of the epidural needle.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or females 18 - 60 years of age
  • Imaging spine study (CT or MRI) in previous 3 months.
  • American Society of Anesthesiologists (ASA) class I-III
  • Patients undergoing elective standard pain relief treatment of Epidural Steroid Injection
  • Patients must be willing to participate in the study, and provide written informed consent
  • Women of child bearing potential must have a negative pregnancy test during the screening and baseline visits or the patient must be surgically sterile or be at least one year postmenopausal
  • Women of child-bearing potential must be using a medically acceptable method of birth control throughout the study such as: bilateral tubal ligation or the use of either a contraceptive implant, a contraceptive injection, an intrauterine device, or an oral contraceptive that has been taken for at least three months, which the subject agrees to continue using during the study, or a double-barrier method which must consist of a combination of any two of the following: diaphragm, cervical cap, condom or spermicide.

排除标准

  • Any contraindications for epidural injection
  • Patient with severe scoliosis
  • Previous spinal surgery, or any additional surgical intervention in the level of epidural injection other than elective standard pain relief treatment of Epidural Steroid Injection.
  • Documented, known or per examination neurological deficiency in lower extremities.
  • Pregnant or breastfeeding patients
  • Patients who have participated in another study within 30 days of enrolment
  • Investigator's opinion that the patient is medically unfit or would be at major risk if enrolled into the study i.e. known coagulopathy or recent use of anticoagulants or anti aggregates.
  • Presence of fever, sepsis or infection near the point of insertion or an infection in the bloodstream which may "seed" onto the catheter
  • Patients with known Hypovolemia
  • Any known Anatomical abnormalities, such as spina bifida, meningomyelocele or scoliosis
  • Patient suffering problems of the central nervous system, including multiple sclerosis or syringomyelia
  • Patients with identified heart-valve problems
  • Patients excessively hirsute where the surface electrodes are to be placed that are unwilling to shave these areas.

结局指标

主要结局

Safety variables collected will include the incidence of adverse events presented by severity, by seriousness and by relationship to study treatment

时间窗: 2 weeks and 1 month post op

次要结局

  • Obtaining real-time bioimpedance measurements in multiple frequencies within the range of 1kHz to 500kHz from human tissues crossed in the epidural needle path.(Day of procedure)

研究者

发起方
ImpediGuide Ltd
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验